onyx pharmaceuticals inc
(OX1:Frankfurt Stock Exchange)
Helen I. Torley M.B. Ch. B., M.R.C.P.
Chief Commercial officer and Executive Vice President, Onyx Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2011
Dr. Helen I. Torley, M.B. Ch. B., M.R.C.P. has been the Chief Commercial Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. since August 29, 2011. Dr. Torley served as Vice President and General Manager of Nephrology Business Unit at Amgen Inc. since October 2003. She joined Amgen Inc. on June 2002 as Therapeutic Area Head of Inflammation Global Marketing. She serves as the Chief Commercial Officer and Executive Vice President at Onyx Pharmaceuticals ...
Corporate Headquarters*249 East Grand Avenue
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Unknown/Other Education 1984
University of Glasgow Scotland
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Richard F. Pops||Chairman and Chief Executive Officer|
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Robert W. Duggan||Chairman and Chief Executive Officer|
|Paul A. Friedman M.D.||Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee|
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$722.2K||Compensation as of Fiscal Year 2012.|